Nuclear Medicine
CLINICAL DECISION SUPPORT
| Clinical Evaluation |
|---|
| Glucose metabolism |
| Type of Imaging |
| PET |
| Grade of Recommendation |
| C/D (optional) |
| Level of Evidence |
| well-established clinical and NM recommendations recommendations |
| Effective Dose |
| 19.0 µSv/MBq |
| Bibliographic Reference |
|
Barrington, S. F., Mikhaeel, N. G., Kostakoglu, L. Role of imaging in the staging and response assessment of lymphoma: consensus of the International...
read more
Barrington, S. F., Mikhaeel, N. G., Kostakoglu, L. Role of imaging in the staging and response assessment of lymphoma: consensus of the International Conference on Malignant Lymphomas Imaging Working Group. J Clin Oncol. 2014; https://doi.org/10.1200/JCO.2013.53.5229
Cheson, B. D., Fisher, R. I., Barrington, S. F. Recommendations for initial evaluation, staging, and response assessment of Hodgkin and non-Hodgkin lymphoma: the Lugano classification. J Clin Oncol, 2014; https://doi.org/10.1200/JCO.2013.54.8800. Nanni, C., Kobe, C., Baeßler, B. European Association of Nuclear Medicine (EANM) Focus 4 consensus recommendations: molecular imaging and therapy in haematological tumours. Lancet Haematol. 2023; https://doi.org/10.1016/S2352-3026(23)00030-3 read less |
| Guide to Nuclear Medicine |
| Read the corresponding chapter |